Novus Therapeutics begins dosing in otitis media drug trial - Drug Development Technology

Novus Therapeutics begins dosing in otitis media drug trial  Drug Development Technology

Novus Therapeutics has commenced dosing in a Phase IIa trial of OP0201 for the treatment of otitis media, an inflammatory disease affecting the middle ear.



Comments

Popular posts from this blog

Uveitis Eye Inflammation Causes, Symptoms & Treatment

Robert Zakar gives back to community

Goopy Eyes: Causes and Treatment